← Eichor
Condition: Juvenile Idiopathic Arthritis Jia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Juvenile Idiopathic Arthritis Jia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dynamic Gait Index as a Functional Gait Assessment Measure in Children With JIA
Phase N/A · 1 location(s) · Istanbul University - Cerrahpasa · NCT06870045Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
Phase N/A · 1 location(s) · Children's National Research Institute · NCT04833465Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial
Phase 4 · 7 location(s) · Oslo University Hospital · NCT06653634Health and Exercise Response in Children With Chronic and Auto-immune Pathologies
NA · 1 location(s) · University Hospital, Clermont-Ferrand · NCT03913962Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, a
Phase N/A · 1 location(s) · National Institute of Arthritis and Musculoskeletal and Skin · NCT03510442Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-medi
Phase N/A · 4 location(s) · Meyer Children's Hospital IRCCS · NCT06862843A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT07517250M3-JIA: Making Mindfulness Matter for Children With JIA
NA · 3 location(s) · London Health Sciences Centre Research Institute OR Lawson R · NCT06376149Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults
Phase N/A · 1 location(s) · Université Catholique de Louvain · NCT07000916Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis
Phase N/A · 1 location(s) · Pfizer · NCT05754710STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS
Phase 3 · 1 location(s) · Istituto Giannina Gaslini · NCT03728478Personalized Estimates of Response and Severity Outcomes in Newly-diagnosed JIA
NA · 1 location(s) · University of British Columbia · NCT05310799CAPRI National Juvenile Idiopathic Arthritis Registry
Phase N/A · 15 location(s) · University of British Columbia · NCT03245801Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Phase N/A · 1 location(s) · Brain Inflammation Collaborative · NCT04806620Evaluation of the Efficacy and Tolerability of an Exclusion Diet in Patients With Juvenile Idiopathic Arthritis
NA · 1 location(s) · Meyer Children's Hospital IRCCS · NCT06874608Ilaris NIS in Korea
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT06838143Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04902807Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
Phase N/A · 1 location(s) · Oregon Health and Science University · NCT07065747Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry
Phase N/A · 9 location(s) · Peking Union Medical College Hospital · NCT06417502Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Even
Phase 3 · 47 location(s) · AbbVie · NCT05609630Feasibility of a Diet Intervention for Juvenile Arthritis
NA · 7 location(s) · The Hospital for Sick Children · NCT06474546Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT07184450A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYP
Phase 2 · 32 location(s) · Sanofi · NCT02991469Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib for the Treatment of Polyarticular-course Juvenile Id
Phase 3 · 14 location(s) · Alfasigma S.p.A. · NCT07554495Virtual Self-Management Program for JIA
NA · 1 location(s) · University of Calgary · NCT06184100To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic A
NA · 10 location(s) · Changchun GeneScience Pharmaceutical Co., Ltd. · NCT05925452Pain in Juvenile Arthritis
NA · 1 location(s) · Washington University School of Medicine · NCT07217782A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With
Phase 3 · 47 location(s) · Bristol-Myers Squibb · NCT06869551Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Phase 4 · 2 location(s) · University of Sao Paulo General Hospital · NCT07087912The BRIDGE Pain Study
Phase N/A · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07602595
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.